Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study

NCT07398560 is registered in ClinicalTrials.gov with The Third Affiliated Hospital of Harbin Medical University as lead sponsor.

NCT NCT07398560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07398560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study
Lead sponsor
The Third Affiliated Hospital of Harbin Medical University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
February 1, 2026
Completion date
February 1, 2029
Enrollment
47 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer